Australia's Cannabis Legal Landscape: State-by-State Breakdown and Market Growth (2024 Update)

A Booming Market with Fragmented Regulations

Australia’s medicinal cannabis sector has experienced explosive expansion since federal legalisation in 2016. Medical cannabis approvals surged 120 percent in the first half of 2023 compared to the preceding year, signalling strong industry momentum. According to Statista forecasts, the Australian cannabis market is projected to reach AU$3.73 billion in 2024, with expectations of steady 3.22 percent annual growth culminating in AU$4.53 billion by 2029.

Yet despite this commercial expansion, Australia’s regulatory framework remains highly fragmented. While medical access has widened, recreational use continues to be prohibited federally, though public sentiment is shifting dramatically. Recent YouGov polling from January 2024 revealed that over 50 percent of Australians favour decriminalisation, and among younger cohorts (18-49 years), half support legalising personal consumption.

The Australian Greens made a landmark move in 2023 by introducing the Legalising Cannabis Bill 2023, marking the nation’s inaugural parliamentary attempt to liberalise cannabis. The proposed legislation would permit citizens aged 18 and above to cultivate up to six plants per household and possess 50 grams of cannabis. Following expert consultation and public feedback addressing concerns about youth access and product standards, the Senate Legal and Constitutional Affairs Committee examined the bill and released its report in May 2024, recommending rejection. However, the Greens have signalled their intention to bring the matter to a Senate vote.

Victoria: First-Mover Advantage in Medical Reform

The question “is weed legal in Victoria?” has a nuanced answer that reflects the state’s pioneering position. Victoria holds the distinction of being Australia’s first jurisdiction to legalise medical cannabis, with initial access granted to children with epilepsy. Any licensed physician can now prescribe medicinal cannabis if deemed clinically appropriate and with proper regulatory clearance.

However, recreational cannabis remains illegal in Victoria. First-time offenders caught with 50 grams or less typically receive a caution and counselling referral rather than criminal charges. Possession exceeding 250 grams or cultivation of 10 or more plants constitutes trafficking.

The state’s reformist trajectory has accelerated recently. A private member’s bill for personal use reform was tabled by a Legalise Cannabis MP and debated in the upper house in December, though it failed to secure government backing. Nonetheless, Victoria’s current Labor administration has expressed openness to further liberalisation measures.

In May 2024, the Victorian government announced a significant pilot initiative—a closed-circuit trial partnered with Swinburne University to evaluate impairment in medical cannabis users. This addresses a critical policy gap: under existing law, drivers detected with any THC trace face mandatory licence suspension and fines, despite THC’s detectability persisting hours post-consumption. The 18-month trial, commencing September 2024, aims to inform evidence-based driving standards. Advocates expressed disappointment that findings won’t be available until late 2025.

New South Wales: Cautionary Approach with Incremental Reform

In New South Wales, cannabis possession, supply and use remain illegal. However, first-time offenders with under 15 grams may receive a caution—up to two cautions are permissible before escalation. A February 2024 expansion allows offenders to complete drug and alcohol intervention programs instead of paying AU$400 fines.

Medical practitioners can prescribe medicinal cannabis without state pre-approval if clinically justified. NSW has invested over AU$9 million in the Centre for Medicinal Cannabis Research and Innovation to support community education, clinical trial monitoring and efficacy research for conditions including epilepsy and cancer-related nausea.

Looking ahead, NSW scheduled its inaugural Parliamentary Drug Summit for 2024 (first since 1999), featuring regional forums in November and Sydney sessions December 4-5. An inquiry into cannabis legalisation’s “socio-economic costs and opportunities,” chaired by Legalise Cannabis MP Jeremy Buckingham, has collected expert and user submissions. The inquiry’s findings will inform summit discussions. NSW Treasurer Daniel Mookhey cautioned that any policy reform would be examined at the summit rather than implemented unilaterally.

Queensland: Strict Penalties Amid Growing Public Support

Queensland maintains harsh recreational cannabis penalties under four different legislative acts. Unlawful possession, supply, production and trafficking attract sentences up to 20 years imprisonment depending on quantities involved.

The state’s medical landscape is more permissive. Following June 2020 legislative changes, any Queensland registered doctor can prescribe Schedule 4 CBD or Schedule 8 THC/CBD oils without formal state health authority approval. However, smoking cannabis remains prohibited—only vapour, capsules, sprays and tinctures are permitted. Medicinal advertising is restricted to medical and pharmaceutical professions only.

Public opinion suggests growing demand for reform. An August 2023 Essential poll showed 50 percent of Queenslanders support legalisation, and Labor members have called for personal possession decriminalisation. Multiple Legalise Cannabis MPs attended MardiGrass 2024, an annual cannabis law reform festival in Nimbin. Additionally, Greens MP Michael Berkman launched a petition urging Queensland to become the nation’s first fully legalised state—accumulating 494 signatures of a 500-target by October 2024.

South Australia: Strongest Public Support Yet Stalled Reform Efforts

South Australia prohibits cannabis flowers, oils and resins entirely. Personal possession faces monetary expiation (fine without criminal conviction), while trafficking risks AU$1 million fines and up to 15 years to life imprisonment.

Medical patients can obtain prescribed cannabis from authorised practitioners, though regulatory approval under Controlled Substances legislation is typically required (with elderly and terminal patient exemptions).

Remarkably, South Australia records the highest public support for legalisation, yet reform attempts remain unsuccessful. In May 2022, Legislative Council member Tammy Franks (South Australian Greens) reintroduced the Cannabis Legalisation Bill 2022, which has languished in legislative process. A September joint committee interim report issued 13 unanimous recommendations, including reforming zero-tolerance roadside drug-testing to protect medicinal users. Government spokespersons indicated recommendations would receive future consideration while maintaining road safety priorities.

Western Australia: Recent Parliamentary Action Following 2011 Reversal

Western Australia previously decriminalised cannabis in 2004 but reversed this in 2011 under Liberal Premier Colin Barnett’s “tough on crime” agenda. Possession of 10 grams or less now results in Cannabis Intervention Requirement (CIR)—a single session attendance option for adults avoiding criminal conviction. Possessing 10-100 grams carries up to AU$2,000 fines and two years imprisonment; over 100 grams attracts enhanced penalties.

Medicinal cannabis is available via prescription from government-approved doctors, dispensed at any pharmacy. However, driving with THC in one’s system remains an offence.

Recent parliamentary activity signals potential movement. Two Legalise Cannabis MPs submitted bills in 2024: one proposing 50-gram possession and six-plant household cultivation limits (debated June 21, 2024, but rejected), and another calling for a referendum question on the March 2025 state election ballot. In September 2024, Dr. Brian Walker of the Legalise Cannabis Party reported the Legislative Council’s approval for reviewing industrial hemp legislation, expressing optimism this reflects “open and healthy debate” potentially leading to economic opportunities worth billions annually for WA.

Tasmania and Northern Territory: Divergent Decriminalisation Models

Tasmania prohibits cannabis possession entirely; even preparation equipment is illegal and attracts maximum fines of AU$7,950. Trafficking 25 grams of oil or one kilogram of plant material carries up to 21 years imprisonment. However, police may issue three warnings for possession under 50 grams.

Medical access improved from July 1, 2021, when general practitioners gained prescription authority (previously requiring specialist referral). GPs can now prescribe if Commonwealth and state approval obtained and clinical appropriateness determined.

The Northern Territory operates a more permissive decriminalisation model. Possession of under 50 grams at home incurs only AU$200 fines, though public possession carries imprisonment risk. Cultivating even five plants risks 200 penalty units or two years imprisonment; commercial quantities (20+ plants) or cultivation “in front of a child” trigger life sentences.

Medicinal cannabis adoption in NT remains low despite Schedule 8 regulation alignment (morphine and oxycodone standards). The first NT script was filled in November 2019, but few authorised prescribers and remote geography limit accessibility. Schedule 4 CBD products can be prescribed without prescriber pre-authorisation.

Australian Capital Territory: Australia’s Sole Recreational Legalisation Jurisdiction

The Australian Capital Territory stands alone as Australia’s only jurisdiction with legalised recreational cannabis. In September 2019, ACT passed legislation effective January 31, 2020, permitting adults 18+ to possess 50 grams of dry cannabis or 150 grams of wet material, and cultivate two plants per person (four household maximum). Exceeding limits triggers fines rather than criminal charges, though plants must remain outdoors.

Critically, ACT’s recreational legalisation conflicts with federal prohibition, and federal lawmakers have repeatedly attempted overturn. This legal tension underscores Australia’s ongoing regulatory fragmentation.

Medical cannabis is available case-by-case for ACT patients with qualifying conditions, requiring doctor approval from the ACT Chief Health Officer and Therapeutic Goods Administration.

The Road Ahead: Regulatory Evolution in a Divided Nation

Australia’s cannabis landscape reflects a nation in transition. While medicinal access has normalised and market projections remain bullish, recreational legalisation remains federally prohibited despite growing public support. The Legalising Cannabis Bill 2023’s parliamentary examination, combined with state-level activism and public sentiment shifts, suggests the next electoral cycle may bring substantive federal-level discussions.

For now, citizens and medical patients navigate vastly different legal environments depending on geography—from ACT’s permissive recreational framework to Tasmania’s absolute prohibition. This patchwork approach continues generating policy innovation, parliamentary engagement and grassroots advocacy as Australia recalibrates its cannabis governance.